Buch, Englisch, 549 Seiten, Format (B × H): 161 mm x 240 mm, Gewicht: 1012 g
Molecular and Neurobiological Foundations
Buch, Englisch, 549 Seiten, Format (B × H): 161 mm x 240 mm, Gewicht: 1012 g
ISBN: 978-0-471-16758-7
Verlag: Wiley
Autoren/Hrsg.
Fachgebiete
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Neuropharmakologie, Psychopharmakologie
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Neurologie, Klinische Neurowissenschaft
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Pharmakologie, Toxikologie
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Psychiatrie, Sozialpsychiatrie, Suchttherapie
- Sozialwissenschaften Psychologie Psychotherapie / Klinische Psychologie
Weitere Infos & Material
I -
The Neurology of Cognition: Structure and Management of Multiple Memory Systems in Alzheimer's Disease;
Interaction of Neuromodulatory Systems Regulating Memory Storage;
Monoamine and Acetylcholine Influences on Higher Cognitive Functions in Nonhuman Primates with Relevance to the Treatment of Alzheimer's Disease;
Cortical Acetylcholine and Attention: Neuropharmacological and Cognitive Principles Directing Treatment Strategies for Cognitive Disorders;
Neuropsychological Features of Alzheimer's Disease;
II -
Neuropathological Features of Alzheimer's Disease;
Normal Brain Ageing and Alzheimer's Disease Pathology;
Recent Developments in the Genetics of Alzheimer's Disease;
Neurofibrillary Tangles in Alzheimer's Disease: Clinical and Pathological Implications;
Amyloid Cytoxicity and Alzheimer's Disease: Roles of Membrane Oxidation and Perturbed Ion Homeostasis;
The Role of Apolipoprotein E in Neurobiology and the Pathogenesis of Alzheimer's Disease;
Animal Models Relevant to Alzheimer's Disease;
III -
Alzheimer's Drug Discovery and Development: Alzheimer's Disease: An International Public Health Problem- Clinical Goals, Strategies and Outcomes;
Use of CSF-based Markers in the Diagnosis of Alzheimer's Disease;
Considerations for Clinical Trials in Alzheimer's Disease;
Cholinesterase Inhibition in the Treatment of Alzheimer's Disease: Further Evaluation of the Clinical Effects of Tucrine;
Development of Muscarinic Agonists for the Symptomatic Treatment of Alzheimer's Disease;
Neuronal Nicotinic Receptors: Potential Treatment for Alzheimer's Disease with Novel Cholinergic Channel Activators;
Neurotrophic Factors: Potential for Therapeutic Intervention in Alzheimer's Disease;
A Fundamental Role for Estrogens in Cognition and Neuroprotection;
Alzheimer's Disease: Prospects for Treatment in the Next Decade.
Partial table of contents:
NEUROBIOLOGY OF COGNITION.
Structure and Dynamics of Multiple Memory Systems in Alzheimer's Disease (R. Kesner & M. Ragozzino).
Monoamine and Acetylcholine Influences on Higher Cognitive Functions in Nonhuman Primates: Relevance to the Treatment of Alzheimer's Disease (A. Arnsten & C. van Dyck).
Neuropsychological Features of Alzheimer's Disease (D. Salmon).
MOLECULAR ASPECTS OF ALZHEIMER'S DISEASE.
Normal Brain Aging and Alzheimer's Disease Pathology (R. Grewal & C. Finch).
Neurofibrillary Tangles in Alzheimer's Disease: Clinical and Pathological Implications (C. Clark, et al.).
ALZHEIMER'S DRUG DISCOVERY AND DEVELOPMENT.
Use of CSF-Based Markers in the Diagnosis of Alzheimer's Disease (P. Seubert, et al.).
Development of Muscarinic Agonists for the Symptomatic Treatment of Alzheimer's Disease (J. Jaen & R. Schwarz).
Conceptual Issues in Research on Inflammation and Alzheimer's Disease (J. Rogers).
Index.
